Figure 2.
(A) Progression-free survival (PFS) by FCGR3A 158 genotype for the chemotherapy only trial, S8809. (B) Progression-free survival (PFS) by FCGR3A 158 genotype for the chemotherapy + mAb trials, S9800 and S9911. Kaplan-Meier curves, with follow up truncated at ten years. 158 F/F (unfavorable) genotype denoted by solid line; 158 V/F genotype denoted by dotted line; 158 V/V genotype denoted by dashed line.